WHAT'S NEW IN CPS
Check out our latest content updates
CPhA is thrilled to share with you the latest additions and updates in CPS.
Content updates
Major updates
The following content has been extensively updated and reviewed by 2 external peer reviewers:
- Viral Skin Infections: Includes common and flat warts; added a new algorithm to guide patient assessment and treatment selection; treatments are now grouped as “first-line treatments” and “other treatments”; added new photos showing different skin tones.
- Prevention and Treatment of Sun-Induced Skin Damage: Several improvements from a diversity, equity and inclusion (DEI) perspective: appearance and risk of sunburn in skin of colour, risks from visible/blue light, information of actinic prurigo; added evidence-based information on sun-protection clothing and UV detection stickers; discussion of sunscreens and coral reef bleaching; risks of benzophenones in children and pregnant people; updated table of medications that can be photosensitizing; added more recommendations from the Canadian Dermatology Association.
- Immunization Resources: Added and updated many links within the table to help find the information on specific conditions in the Canadian Immunization Guide; added information on Ebola and updated other products throughout the table.
- Frostbite: Now covers two classification systems, according to thickness and according to proximal extent of the injury; added new information on treatment with ilopost.
Minor updates
The following content has been reviewed to ensure that it is current:
- Dementia: Added information on new treatment, lecanemab (Leqembi).
- Vaginal Symptoms, Hygiene and Infections: Routine review.
Drug monographs
The following drug monographs were recently added:
- Zepbound: Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist.
- Nduvra: Aryl Hydrocarbon Receptor Agonist.
- Lyvdelzi: Selective peroxisome proliferator-activated receptor (PPAR)δ agonist.
- Jaypirca: Bruton Tyrosine Kinase (BTK) Inhibitor.
Check out what’s new in CPS to learn more.
